Last Posted: Feb 05, 2020
- Pharmacogenomic landscape of VIP genetic variants in Jordanian Arabs and comparison with worldwide populations.
Al-Eitan Laith N et al. Gene 2020 Jan 144408 - A precision medicine–based strategy for a severe adverse drug reaction
MR Mack et al, Nature Medicine, February 3, 2020 - Drug Use in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines from CPIC or DPWG for CYP2D6 and CYP2C19 Drug-Gene Pairs: Perspectives for Introducing PGx Test to Polypharmacy Patients.
Westergaard Niels et al. Journal of personalized medicine 2020 Jan 10(1) - Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.
Qin Weifeng et al. Pharmacogenomics 2020 Feb 21(3) 209-219 - Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice.
Przybylski Daniel J et al. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2020 Jan 1078155219896395 - Pharmacogenomics at the center of precision medicine: challenges and perspective in an era of Big Data.
Primorac Dragan et al. Pharmacogenomics 2020 Jan 21(2) 141-156 - Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation.
King Charlotte et al. The pharmacogenomics journal 2020 Jan - Clinical Pharmacogenomics: Applications in Nephrology.
Adams Solomon M et al. Clinical journal of the American Society of Nephrology : CJASN 2018 13(10) 1561-1571 - PGxCorpus, a manually annotated corpus for pharmacogenomics.
Legrand Joël et al. Scientific data 2020 7(1) 3 - Association of carbamazepine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients
F Capule et al, PGX journal. January 3, 2020
.jpeg)
No hay comentarios:
Publicar un comentario